|
"yen cj"的相關文件
顯示項目 61-85 / 99 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2015-05 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
Chen, JS;Hsu, C;Chiang, NJ;Tsai, CS;Tsou, HH;Huang, SF;Bai, LY;Chang, IC;Shiah, HS;Ho, CL;Yen, CJ;Lee, KD;Chiu, CF;Rau, KM;Yu, MS;Yang, Y;Hsieh, RK;Chang, JY;Shan, YS;Chao, Y;Chen, LT |
| 國家衛生研究院 |
2015-03 |
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer
|
Lee, WT;Huang, CC;Chen, KC;Wong, TY;Ou, CY;Tsai, ST;Yen, CJ;Fang, SY;Lo, HI;Wu, YH;Hsueh, WT;Yang, MW;Lin, FC;Hsiao, JR;Huang, JS;Chang, JY;Chang, KY;Wu, SY;Lin, CL;Wang, YH;Weng, YL;Yang, HC;Chang, JS |
| 國家衛生研究院 |
2014-11 |
The interplay between alcohol consumption, oral hygiene, ALDH2 and ADH1B in the risk of head and neck cancer
|
Tsai, ST;Wong, TY;Ou, CY;Fang, SY;Chen, KC;Hsiao, JR;Huang, CC;Lee, WT;Lo, HI;Huang, JS;Wu, JL;Yen, CJ;Hsueh, WT;Wu, YH;Yang, MW;Lin, FC;Chang, JY;Chang, KY;Wu, SY;Liao, HC;Lin, CL;Wang, YH;Weng, YL;Yang, HC;Chang, JS |
| 國立成功大學 |
2014-11 |
Results of a phase I, open-label, multicentre study to assess the safety, tolerability, pharmacokinetics and preliminary antitumour activity of AZD9150 in patients with advanced/metastatic hepatocellular carcinoma
|
Kang, Y. K.; Ryoo, BY; Kim, TY; Lee, KH; Lim, HY; Lee, SJ; Ikeda, M; Okusaka, T; Nadano, S; Lin, CC; Poon, TP; Yen, CJ; McCoon, P; Neumann, F; Vishwantahan, K; DuPont; Lyne, P |
| 國家衛生研究院 |
2014-10-24 |
Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5year follow-up
|
Wu, SY;Wu, YH;Yang, MW;Hsueh, WT;Hsiao, JR;Tsai, ST;Chang, KY;Chang, J;Yen, CJ |
| 國家衛生研究院 |
2014-07 |
Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of High-Dose 5-Fluorouracil and Leucovorin as first-line treatment for patients with advanced gastric cancer
|
Shen, YC;Li, CP;Yen, CJ;Hsu, C;Lin, YL;Lin, ZZ;Chen, LT;Su, WC;Chao, Y;Yeh, KH;Cheng, AL |
| 中國醫藥大學 |
2014-06 |
Development of a Highly Sensitive Glycan Microarray for Quantifying AFP-L3 for Early Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma
|
(Wu CS);(Lee TY);鄒瑞煌(Ruey-Hwang Chou);(Yen CJ);黃偉謙(Wei-Chien Huang);(Wu CY);余永倫(Yung-Luen Yu)* |
| 國家衛生研究院 |
2014-05-05 |
Tea consumption and risk of head and neck cancer
|
Huang, CC;Lee, WT;Tsai, ST;Ou, CY;Lo, HI;Wong, TY;Fang, SY;Chen, KC;Huang, JS;Wu, JL;Yen, CJ;Hsueh, WT;Wu, YH;Yang, MW;Lin, FC;Chang, JY;Chang, KY;Wu, SY;Hsiao, JR;Lin, CL;Wang, YH;Weng, YL;Yang, HC;Chang, JS |
| 亞洲大學 |
2014-04 |
Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression.
|
Wu, CS;Wu, CS;Yen, CJ;Yen, CJ;鄒瑞煌;Chou, Ruey-Hwang;Chen, JN;Chen, JN;Huang, WC;Huang, WC;Wu, CY;Wu, CY;余永倫 |
| 中國醫藥大學 |
2014-04 |
Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2–induced Globo H expression
|
吳承修;(Yen CJ);鄒瑞煌(Ruey-Hwang Chou);陳佳妮;黃偉謙(Wei-Chien Huang);(Wu CY);余永倫(Yung-Luen Yu)* |
| 國家衛生研究院 |
2013-10 |
Investigating the association between oral hygiene and head and neck cancer
|
Chang, JS;Lo, HI;Wong, TY;Huang, CC;Lee, WT;Tsai, ST;Chen, KC;Yen, CJ;Wu, YH;Hsueh, WT;Yang, MW;Wu, SY;Chang, KY;Chang, JY;Ou, CY;Wang, YH;Weng, YL;Yang, HC;Wang, FT;Lin, CL;Huang, JS;Hsiao, JR |
| 國家衛生研究院 |
2013-06-27 |
Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance
|
Chang, KY;Tsai, SY;Chen, SH;Tsou, HH;Yen, CJ;Liu, KJ;Fang, HL;Wu, HC;Chuang, BF;Chou, SW;Tang, CK;Liu, SY;Lu, PJ;Yen, CY;Chang, JY |
| 國家衛生研究院 |
2013-06 |
SUMOylated CPAP is required for IKK-mediated NF-kappaB activation and enhances HBx-induced NF-kappaB signaling in HCC
|
Yang, ST;Yen, CJ;Lai, CH;Lin, YJ;Chang, KC;Lee, JC;Liu, YW;Chang-Liao, PY;Hsu, LS;Chang, WC;Hung, WC;Tang, TK;Liu, YW;Hung, LY |
| 國家衛生研究院 |
2013-06 |
Oral hygiene and risk of head and neck cancer
|
Chang, J;Hsiao, JR;Ou, CY;Lo, HI;Huang, CC;Lee, WT;Huang, JS;Chen, KC;Wong, TY;Tsai, ST;Yen, CJ;Wu, YH;Hsueh, WT;Yang, MW;Wu, SY;Chang, JY;Chang, KY;Wang, YH;Weng, YL;Yang, HC;Lin, CL;Wang, FT |
| 國家衛生研究院 |
2013-04 |
EGFR variant III act as the major determinant factors in the EGFR/PI3K/AKT pathway for the survival outcome of oral cancer patients
|
Chang, KY;Tsai, SY;Chen, SH;Tsou, HH;Yen, CJ;Tang, CK;Yen, CY;Chang, JY |
| 國家衛生研究院 |
2013-02-01 |
Allergies and risk of head and neck cancer: An original study plus meta-analysis
|
Hsiao, JR;Ou, CY;Lo, HI;Huang, CC;Lee, WT;Huang, JS;Chen, KC;Wong, TY;Tsai, ST;Yen, CJ;Wu, YH;Hsueh, WT;Yang, MW;Wu, SY;Chang, JY;Chang, KY;Lin, CL;Wang, FT;Wang, YH;Weng, YL;Yang, HC;Chang, JS |
| 國家衛生研究院 |
2013-02 |
Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients
|
Hsieh, YH;Su, IJ;Yen, CJ;Tsai, TF;Tsai, HW;Tsai, HN;Huang, YJ;Chen, YY;Ai, YL;Kao, LY;Hsieh, WC;Wu, HC;Huang, W |
| 臺北醫學大學 |
2013 |
Dissecting the EGFR-P13K-AKT pathway in oral cancer highlights the roles of the EGFR variant III and its clinical relevance
|
Chang, KY;Tsia, SY;Chen, SH;Tsou, HH;Yen, CJ;Liu, KJ;Fang, HL;Wu, HC;Chuang, BF;Chou, SW;Tang, CK;Liu, SY;Lu, PJ;Yen, CY;chang, JY |
| 國家衛生研究院 |
2012-07-27 |
Hepatitis B virus X protein upregulates mTOR signaling through IKKBeta to increase cell proliferation and VEGF production in hepatocellular carcinoma
|
Yen, CJ;Lin, YJ;Yen, CS;Tsai, HW;Tsai, TF;Chang, KY;Huang, WC;Lin, PW;Chiang, CW;Chang, TT |
| 國家衛生研究院 |
2011-11-15 |
Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo
|
Chang, KY;Tsai, SY;Wu, CM;Yen, CJ;Chuang, BF;Chang, JY |
| 國家衛生研究院 |
2011-09-23 |
A phase II study of neoadjuvant bio-chemotherapy with Cetuximab, Paclitaxel, and Cisplatin (CPC) followed by Cetuximab-based concurrent bio-radiotherapy in high-risk locally advanced head and neck cancer - representative of head and neck cancer study grou
|
Chang, KY;Yen, CJ;Hsieh, CY;Tsou, HH;Chiu, CF;Chen, CC;Tsao, CJ;Tsai, KY;Tsai, ST;Chang, JY |
| 國家衛生研究院 |
2011-09 |
Phase II study of low-dose everolimus plus weekly cisplatin and 24-hour infusion of high-dose 5-fluorouracil and leucovorin for first-line treatment of metastatic or recurrent gastric cancers
|
Yeh, K;Shen, YC;Li, CP;Yen, CJ;Lin, YL;Lin, ZZ;Chen, LT;Su, WC;Chao, Y;Cheng, AL |
| 國家衛生研究院 |
2011-07-01 |
A clustered ground-glass hepatocyte pattern represents a new prognostic marker for the recurrence of hepatocellular carcinoma after surgery
|
Tsai, HW;Lin, YJ;Lin, PW;Wu, HC;Hsu, KH;Yen, CJ;Chan, SH;Huang, W;Su, IJ |
| 國家衛生研究院 |
2011-06-23 |
Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells
|
Chen, YJ;Huang, WC;Wei, YL;Hsu, SC;Yuan, P;Lin, HY;Wistuba, I;Lee, JJ;Yen, CJ;Su, WC;Chang, KY;Chang, WC;Chou, TC;Chou, CK;Tsai, CH;Hung, MC |
| 國家衛生研究院 |
2010-10 |
A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer
|
Li, CP;Chen, JS;Chen, LT;Yen, CJ;Lee, KD;Su, WP;Lin, PC;Lu, CH;Tsai, HJ;Chao, Y |
顯示項目 61-85 / 99 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目
|
